David W. Archibald

516 total citations
15 papers, 428 citations indexed

About

David W. Archibald is a scholar working on Virology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David W. Archibald has authored 15 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Virology, 6 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David W. Archibald's work include HIV Research and Treatment (6 papers), HIV/AIDS oral health manifestations (5 papers) and Herpesvirus Infections and Treatments (3 papers). David W. Archibald is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS oral health manifestations (5 papers) and Herpesvirus Infections and Treatments (3 papers). David W. Archibald collaborates with scholars based in United States. David W. Archibald's co-authors include G A Cole, Max Essex, Carla Hebert, M. F. McLane, Di Sun, Stephen J. Meltzer, John J. Sauk, Charles E. Barr, M. S. Hirsch and D E Craven and has published in prestigious journals such as Cancer, Annals of the New York Academy of Sciences and Journal of Clinical Microbiology.

In The Last Decade

David W. Archibald

15 papers receiving 413 citations

Peers

Countries citing papers authored by David W. Archibald

Since Specialization

Citations

This map shows the geographic impact of David W. Archibald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Archibald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Archibald more than expected).

Fields of papers citing papers by David W. Archibald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Archibald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Archibald. The network helps show where David W. Archibald may publish in the future.

Co-authorship network of co-authors of David W. Archibald

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Archibald. A scholar is included among the top collaborators of David W. Archibald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Archibald. David W. Archibald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Risk of acquiring AIDS from salivary exchange through cardiopulmonary resuscitation courses and mouth-to-mouth resuscitation 1995 ·PubMed ·Di Sun, Robert M. Bennett, David W. Archibald	21
2	Loss of heterozygosity involving the APC gene in oral squamous cell carcinomas 1994 ·Oral Surgery Oral Medicine Oral Pathology ·(unknown), Stephen J. Meltzer, John J. Sauk, Carla Hebert, David W. Archibald	30
3	Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction 1993 ·Cancer ·(unknown), Stephen J. Meltzer, Jing Yin, Kathleen Norris, John J. Sauk, David W. Archibald	43
4	Practical Applications for Saliva in Perinatal HIV Diagnosis^a 1993 ·Annals of the New York Academy of Sciences ·David W. Archibald, John Farley, Carla Hebert, Susan E. Hines, Prasanna Nair, John P. Johnson	6
5	Effects of Human Salivas on Recombinant HIV-1 Proteins 1993 ·Critical Reviews in Oral Biology & Medicine ·David W. Archibald, Carla Hebert, (unknown), George K. Lewis	4
6	Salivary Detection of HIV-1 Antibodies Using Recombinant HIV-1 Peptides 1991 ·Viral Immunology ·David W. Archibald, Carla Hebert	16
7	Variation of Secretory Antibodies in Parotid Saliva to Human Immunodeficiency Virus Type 1 with HIV-1 Disease Stage 1990 ·AIDS Research and Human Retroviruses ·Di Sun, David W. Archibald, Priscilla A. Furth	24
8	In Vitro Inhibition of HIV-1 Infectivity by Human Salivas 1990 ·AIDS Research and Human Retroviruses ·David W. Archibald, G A Cole	84
9	Detection of salivary immunoglobulin A antibodies to HIV-1 in infants and children 1990 ·AIDS ·David W. Archibald, John P. Johnson, Prasanna Nair, Lindsay S. Alger, Carla Hebert, (unknown), Susan E. Hines	27
10	Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial. 1990 ·PubMed ·David W. Archibald, Carla Hebert, Di Sun, C O Tacket	15
11	Achieving the BTC Qualification 1987 ·Psychiatric Bulletin ·(unknown), (unknown), David W. Archibald	2
12	Antibodies to Human Immunodeficiency Virus in Cervical Secretions from Women at Risk for AIDS 1987 ·The Journal of Infectious Diseases ·David W. Archibald, (unknown), D E Craven, Markus Vogt, M. S. Hirsch, Max Essex	54
13	Secretory IgA Antibodies to Human Immunodeficiency Virus in the Parotid Saliva of Patients with AIDS and AIDS-Related Complex 1987 ·The Journal of Infectious Diseases ·David W. Archibald, Charles E. Barr, (unknown), M. F. McLane, Max Essex	53
14	Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection 1986 ·Journal of Clinical Microbiology ·David W. Archibald, (unknown), JE Groopman, J.S. Allan, M. F. McLane, Max Essex	44
15	The evaluation of a cough suppressant: an exercise in clinical pharmacology. 1959 ·PubMed ·David W. Archibald, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact